Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization.
Zhu T, Goodarzi MO.
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e899-e911. doi: 10.1210/clinem/dgab757.
Hormone replacement therapy - where are we now?
Langer RD, Hodis HN, Lobo RA, Allison MA.
Climacteric. 2021 Feb;24(1):3-10. doi: 10.1080/13697137.2020.1851183. Epub 2021 Jan 6.
Medical Treatment of Female Sexual Dysfunction.
Nappi RE, Tiranini L, Martini E, Bosoni D, Righi A, Cucinella L.
Urol Clin North Am. 2022 May;49(2):299-307. doi: 10.1016/j.ucl.2022.02.001.
Polycystic ovary syndrome.
Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K, Piltonen TT.
Nat Rev Dis Primers. 2024 Apr 18;10(1):27. doi: 10.1038/s41572-024-00511-3.
Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.
Sullivan SD, Sarrel PM, Nelson LM.
Fertil Steril. 2016 Dec;106(7):1588-1599. doi: 10.1016/j.fertnstert.2016.09.046.
Management of genitourinary syndrome of menopause in breast cancer survivors: An update.
Lubián López DM.
World J Clin Oncol. 2022 Feb 24;13(2):71-100. doi: 10.5306/wjco.v13.i2.71.
Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review.
Okoth K, Chandan JS, Marshall T, Thangaratinam S, Thomas GN, Nirantharakumar K, Adderley NJ.
BMJ. 2020 Oct 7;371:m3502. doi: 10.1136/bmj.m3502.
The epidemiology of hidradenitis suppurativa.
Ingram JR.
Br J Dermatol. 2020 Dec;183(6):990-998. doi: 10.1111/bjd.19435. Epub 2020 Sep 3.
Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.
Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, Santen RJ.
J Clin Endocrinol Metab. 2015 Nov;100(11):3975-4011. doi: 10.1210/jc.2015-2236. Epub 2015 Oct 7.
Vaginal Rejuvenation: A Retrospective Review of Lasers and Radiofrequency Devices.
Juhász MLW, Korta DZ, Mesinkovska NA.
Dermatol Surg. 2021 Apr 1;47(4):489-494. doi: 10.1097/DSS.0000000000002845.
